In this study children were more commonly exposed to pertussis by a sibling (22/26) than a parent, and 25 ofthe 26 children and adults responsible for transmitting the infection had typical disease. Atypical disease occurred in older children and parents but was almost exclusively associated with secondary rather than primary infection. Furthermore, isolation of B pertussis (which may reflect a person's infectiousness) was more common in those with typical pertussis (l6 of46 who had swabs taken) than in those who were asymptomatic or had atypical pertussis (one of 25 who had swabs taken). These results could not have -been influenced by erythromycin treatment as the only family members treated in this way were children with typical pertussis (17/43).
Near fatal drug interactions with methotrexate given for psoriasis Methotrexate and trimethoprim are folate antagonists which, given together5 may produce a synergistic effect on folate metabolism. Non-steroidal anti-inflammatory drugs may also interact with methotrexate. I We describe a patient who developed necrotic skin ulceration and pancytopenia after concurrent administration of methotrexate, trimethoprim, and naproxen.
Case report An 80 year old woman with a 24 year history of psoriasis was started on intramuscular methotrexate in June 1986 because her psoriasis had deteriorated. Treatment with oral methotrexate in 1%7-8 had been discontinued because of a slight increase in serum transaminase activities; since then she had been managed with topical steroids and tar.
From June to September 1986 she received three 15 mg injections of methotrexate. Two more (25 mg each) were given in October and November. The sixth injection (25 mg methotrexate) was given in January 1987, seven weeks after the fifth. Concurrent therapy was naproxen, 250 mg twice daily, which she had started in August 1986, before the second methotrexate injection.
Renal function was unremarkable in June 1986 (urea 8-6 mmol/l, creatinine 99 pmol/l). Before the sixth injection the blood count was normal (haemoglobin 120 g/l, white cell count 9 4x 109/1, and platelet count 219x 109/1); five days later, however, she presented with painful, ulcerated areas and contact bleeding over the thighs, buttocks, back, and upper chest (figure). Five days before the sixth injection she had started taking trimethoprim 200 mg twice daily for a urinary tract infection. Investigation showed severe neutropenia (white cell count 0 9x 109/l, neutrophils 0 3x109/l, haemoglobin 114 g/l, and platelet count 200x109/l), slightly raised urea concentration (13-3 mmol/l), and a red cell folate concentration of 504 y&/l (nornial 125-600 sg/l). We considered that the methotrexate and trimethoprim had interacted, producing skin ulceration and leucopenia.
Folinic acid 60 mg daily was started. The white cell count rose to 3-5 x 109/l by day 7; the platelet count fell to 36x 109/1 but recovered and was normal from day 9. The urea concentration rose by day 3 owing to dehydration (urea 20*2 mmol/l, creatinine 99 plmol/l), and folinic acid was continued to cover delayed excretion of methotrexate. The skin healed and contact bleeding had stopped by day 7. The urea concentration was normal on day 8 (5 3 mmol/l).
On day 8, when still neutropenic (neutrophils 1 7x 109/l), she developed pneumonia. She received gentamicin, piperacillin, and metronidazole and dobutamine for cardiogenic shock. She was comatose for about 24 hours, but by day 10 she was conscious and well perfused. The white cell count was then 15 3x 109/1. Folinic acid, metronidazole, and dobutamine were stopped, and she continued taking oral antibiotics.
Her recovery was complicated by temporary renal impairment and an acute confusional state lasting about 10 days. She was discharged one month later.
Comment
The recommended intramuscular dose ofmethotrexate in psoriasis is 7 5-50 mg weekly.2 In this case a full blood count was normal before each methotrexate injection.
Methotrexate is excreted unchanged, principally through the kidneys by glomerular filtration and active secretion,2 and impaired renal function may necessitate a reduced dosage. Our patient gave no suggestion of impaired renal function before the sixth injection of methotrexate, although she had had a urinary tract infection. 
Undescended testes in low birthweight infants
Cryptorchidism is a known risk factor for infertility and testicular malignancy. The reported incidence is rising and is now over 2%,' bilateral abnormality occurring in 10-25% of cases. Undescended testes are more common in low birthweight infants,2 but there is little detailed information on this subgroup. We collected extensive data on preterm infants, enabling us to determine the incidence of cryptorchidism and its associations.
Patients methods, and results
Altogether 355 male infants with birth weights under 1850 g who had been admitted to Cambridge, Norwich, Ipswich, or Kings Lynn in 1982 or 1983 and all units in East Anglia in 1984, were examined by one ofus (RM) at 18 months after term. An undescended testis was defined as one that could not be brought down to the bottom of the scrotum by manipulation (alternatively, a previous operative diagnosis was taken).
The overall incidence of undescended testes was 35/355 (9-9"%). Cryptorchidism was strongly related to birth weight (table). In infants below and above 1500 g the incidence was 29/186 (16%) and 6/169 (3-6%), respectively (p=0(001). Bilateral abnormality occurred in 15 ofthe 35 cases (43%). Ofthe 260 infants born at up to 32 weeks' gestation, 33 (13%) had undescended testes compared with two of the 95 (2%) born after 32 weeks (p<0-01). A birth weight of under 1850 g was the criterion for entry to this study; thus larger infants born after 31 weeks were excluded. Undescended testes were, however, unrelated to being small for gestational age.
Extensive data on antenatal, perinatal, and postnatal factors, collected in a subgroup of 287 infants enrolled in a preterm feeding trial,' showed significant associations between undescended testes and both necrotising enterocolitis (p=0 025) and eczema at 18 months (p=0001; table) (enterocolitis and eczema were evenly distributed across the range ofbirth weight). Cryptorchidism tended to be more common in infants whose mothers had been given steroids (8/44 (18%) compared with 21/243 (8-6%); p=0 053). No significant associations were found with maternal age or parity, conception while the mother was taking oestrogens, breech delivery, phototherapy (which affects plasma luteinising hormone concentration4), severity of neonatal respiratory disease, or any other factor analysed.
Comment
Cryptorchidism emerges as one of the commonest abnormalities in surviving male infants of very low birth weight, occurring in 190/o of those weighing below 1000 g. Testicular descent, normally a late fetal event, may be interrupted by preterm birth; interestingly, in infants born after 32 weeks' gestation the incidence of cryptorchidism was similar to that reported in infants born at term. We failed to find an association between undescended testes and factors described previously.' The association between undescended testes and necrotising enterocolitis may be a chance finding, given that multiple factors were analysed, but intra-abdominal disease might interfere with testicular descent. The association with eczema is probably not a chance finding. Given the trend towards a higher incidence of cryptorchidism in the small group whose mothers received steroids, we speculate that cutaneous absorption of corticosteroid creams for infantile eczema may interfere with the descent of testes.
We calculate that an increase in the survival of infants weighing under 1500 g from 50%/o to 80% (as occurred in Cambridge during 1952-82) would increase the incidence of undescended testes in the population by only 0-04%, which does not account for the reported secular rise from around 1% to 2%.
